114 related articles for article (PubMed ID: 25097604)
1. Trends in breast cancer incidence rates by age and tumor characteristics of women in the city of Isfahan for the period 2001-2010: An application of joinpoint analysis.
Tazhibi M; Dehkordi ZF; Babazadeh S
J Res Med Sci; 2014 Apr; 19(4):319-25. PubMed ID: 25097604
[TBL] [Abstract][Full Text] [Related]
2. Application of joinpoint regression in determining breast cancer incidence rate change points by age and tumor characteristics in women aged 30-69 (years) and in Isfahan city from 2001 to 2010.
Dehkordi ZF; Tazhibi M; Babazade S
J Educ Health Promot; 2014; 3():115. PubMed ID: 25540788
[TBL] [Abstract][Full Text] [Related]
3. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
Jemal A; Ward E; Thun MJ
Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer Incidence Trends in Isfahan Province Compared with those in England over the Period 2001-2013.
Ainvand MH; Shakibaei N; Ravankhah Z; Yadegarfar G
Int J Prev Med; 2021; 12():54. PubMed ID: 34447496
[TBL] [Abstract][Full Text] [Related]
5. Rising incidence rates of breast carcinoma with micrometastatic lymph node involvement.
Cronin-Fenton DP; Ries LA; Clegg LX; Edwards BK
J Natl Cancer Inst; 2007 Jul; 99(13):1044-9. PubMed ID: 17596573
[TBL] [Abstract][Full Text] [Related]
6. Trends in the incidence and mortality of kidney cancer in Lithuania from 1993 to 2012.
Patašius A; Ulytė A; Ulys A; Smailytė G
Acta Med Litu; 2018; 25(3):151-160. PubMed ID: 30842704
[TBL] [Abstract][Full Text] [Related]
7. Trends in prostate cancer incidence and mortality in a mid-sized Northeastern Brazilian city.
Lima CA; Silva AM; Kuwano AY; Rangel MR; Macedo-Lima M
Rev Assoc Med Bras (1992); 2013; 59(1):15-20. PubMed ID: 23440137
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
[TBL] [Abstract][Full Text] [Related]
9. Trends in incidence of lung cancer in Croatia from 2001 to 2013: gender and regional differences.
Siroglavić KJ; Polić Vižintin M; Tripković I; Šekerija M; Kukulj S
Croat Med J; 2017 Oct; 58(5):358-363. PubMed ID: 29094814
[TBL] [Abstract][Full Text] [Related]
10. Trend of breast cancer mortality in Montenegro, 1990-2018 - Joinpoint regression.
Vuković MMN; Laušević DB; Vućković LM; Bukumirić ZM
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):3849-3857. PubMed ID: 35731054
[TBL] [Abstract][Full Text] [Related]
11. Worldwide trends in breast cancer incidence from 1993 to 2012: Age-period-cohort analysis and joinpoint regression.
Krishnamoorthy Y; Rajaa S; Giriyappa DK; Bharathi A; Velmurugan B; Ganesh K
J Res Med Sci; 2020; 25():98. PubMed ID: 33273943
[TBL] [Abstract][Full Text] [Related]
12. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
13. Increasing thyroid cancer incidence in Lithuania in 1978-2003.
Smailyte G; Miseikyte-Kaubriene E; Kurtinaitis J
BMC Cancer; 2006 Dec; 6():284. PubMed ID: 17156468
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory and other breast cancer incidence rate trends by estrogen receptor status in the Surveillance, Epidemiology, and End Results database (2001-2015).
Aurit SJ; Devesa SS; Soliman AS; Schairer C
Breast Cancer Res Treat; 2019 Jun; 175(3):755-764. PubMed ID: 30915662
[TBL] [Abstract][Full Text] [Related]
15. Time trends in breast cancer incidence and mortality in a mid-sized northeastern Brazilian city.
Lima CA; Rangel MR; Macedo-Lima M; da Silva AM
BMC Public Health; 2012 Oct; 12():883. PubMed ID: 23078090
[TBL] [Abstract][Full Text] [Related]
16. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
17. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer in Iranian Woman: Incidence by Age Group, Morphology and Trends.
Rafiemanesh H; Salehiniya H; Lotfi Z
Asian Pac J Cancer Prev; 2016; 17(3):1393-7. PubMed ID: 27039778
[TBL] [Abstract][Full Text] [Related]
19. Breast Cancer Trend in Iran from 2000 to 2009 and Prediction till 2020 using a Trend Analysis Method.
Zahmatkesh B; Keramat A; Alavi N; Khosravi A; Kousha A; Motlagh AG; Darman M; Partovipour E; Chaman R
Asian Pac J Cancer Prev; 2016; 17(3):1493-8. PubMed ID: 27039796
[TBL] [Abstract][Full Text] [Related]
20. Trends in the Incidence and Mortality of Diabetes in China from 1990 to 2017: A Joinpoint and Age-Period-Cohort Analysis.
Liu X; Yu C; Wang Y; Bi Y; Liu Y; Zhang ZJ
Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626127
[No Abstract] [Full Text] [Related]
[Next] [New Search]
